Vincogen Corporation (Vincogen) is a privately held service company engaged in developing of biochips used in screening of biological samples for the presence of disease. The company mainly focuses on the technologies namely: proteomics, molecular diagnostics and pharmaceuticals which help in developing the right medicine. The product pipeline of the company which is in various phases of development includes human vaccines, veterinary vaccines, bio-generic drugs and industrial enzymes. Vincogen also develops RF integrated circuit chip for bioassays. In addition to this, the company offers services that include research and development, patent and libraries licensing. The company is headquartered at North Brunswick in New Jersey, the US.